4.6 Article

Exercise Training in Older Patients With Heart Failure and Preserved Ejection Fraction A Randomized, Controlled, Single-Blind Trial

期刊

CIRCULATION-HEART FAILURE
卷 3, 期 6, 页码 659-667

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCHEARTFAILURE.110.958785

关键词

heart failure; aging; exercise

资金

  1. National Institutes of Health (NIH) [R37AG18915, R01AG12257]
  2. Claude D. Pepper Older Americans Independence Center of Wake Forest University [NIH P30AG21332]
  3. General Clinical Research Center of the Wake Forest University School of Medicine [NIH M01RR07122]
  4. Synvista
  5. Bristol-Meyers-Squibb
  6. Novartis
  7. Boston Scientific
  8. Relypsa
  9. Forest Laboratories
  10. Medtronic

向作者/读者索取更多资源

Background-Heart failure (HF) with preserved left ventricular ejection fraction (HFPEF) is the most common form of HF in the older population. Exercise intolerance is the primary chronic symptom in patients with HFPEF and is a strong determinant of their reduced quality of life (QOL). Exercise training (ET) improves exercise intolerance and QOL in patients with HF with reduced ejection fraction (EF). However, the effect of ET in HFPEF has not been examined in a randomized controlled trial. Methods and Results-This 16-week investigation was a randomized, attention-controlled, single-blind study of medically supervised ET (3 days per week) on exercise intolerance and QOL in 53 elderly patients (mean age, 70 +/- 6 years; range, 60 to 82 years; women, 46) with isolated HFPEF (EF >= 50% and no significant coronary, valvular, or pulmonary disease). Attention controls received biweekly follow-up telephone calls. Forty-six patients completed the study (24 ET, 22 controls). Attendance at exercise sessions in the ET group was excellent (88%; range, 64% to 100%). There were no trial-related adverse events. The primary outcome of peak exercise oxygen uptake increased significantly in the ET group compared to the control group (13.8 +/- 2.5 to 16.1 +/- 2.6 mL/kg per minute [change, 2.3 +/- 2.2 mL/kg per minute] versus 12.8 +/- 2.6 to 12.5 +/- 3.4 mL/kg per minute [change, -0.3 +/- 2.1 mL/kg per minute]; P = 0.0002). There were significant improvements in peak power output, exercise time, 6-minute walk distance, and ventilatory anaerobic threshold (all P < 0.002). There was improvement in the physical QOL score (P = 0.03) but not in the total score (P = 0.11). Conclusions-ET improves peak and submaximal exercise capacity in older patients with HFPEF. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01113840.(Circ Heart Fail.2010;3:659-667.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据